Key documents from the latest MPAC meeting available

MPAC meeting, March 2013
Pierre Albouy/ WHO

30 September 2015 – The Malaria Policy Advisory Committee reviewed the recommendations of expert groups on the use of mass drug administration for malaria; prevention and treatment of malaria in pregnancy; and vector control coverage. It also heard updates on artemisinin and ACT resistance in the Greater Mekong subregion, malaria elimination in the WHO European Region, and the ongoing process to update malaria terminology. Other topics on the agenda included G6PD testing before treatment and the latest updates on the RTS,S vaccine candidate.

New WHO/UNICEF report on achieving the malaria MDG target

The Global Fund/Guy Stubbs

17 September 2015 – According to a joint WHO/UNICEF report released today, the rate of new malaria cases has dropped by 37% globally over the past 15 years, while mortality fell by 60%. The report, Achieving the Malaria MDG Target, shows that the malaria target of the Millennium Development Goals has been met “convincingly”. However, malaria remains an acute public health problem in many regions, above all in sub-Saharan Africa where 15 countries accounted for 80% of malaria cases and 78% of deaths globally in 2015.

New web section: Malaria rapid diagnostic tests

National Malaria Control Programme/ Madagascar

27 August 2015 – Early and accurate diagnosis of malaria is essential to appropriately target treatment and guide management of febrile illnesses. Access to rapid diagnostic tests (RDTs), one of the two WHO-recommended methods for testing suspected malaria cases, is increasing worldwide. Between 2008 and 2013, the volume of RDT sales in endemic countries rose from 46 to 319 million, making the production and selection of high-quality RDT a critical process. This new section provides guidance for organizations and individuals considering the use of RDTs, as well as for malaria control programmes, health services and test kit manufacturers.


Latest news

30 September 2015 – New update on artemisinin resistance

A new update is available on the status of artemisinin resistance in affected countries. The update also summarizes WHO's current policy and treatment recommendations, and highlights areas of concern.

27 August 2015 – Seventh MPAC meeting report available in Malaria Journal

The report on the March 2015 Malaria Policy Advisory Committee meeting is now available. The report and all related documentation can be consulted on the dedicated MPAC meetings page.

25 August 2015 – WHO commends RBM's contribution to global progress

The Roll Back Malaria (RBM) Partnership is to restructure to meet the new challenges posed in the post-2015 era. The governing board has recommended disbanding the current RBM secretariat hosted by WHO in Geneva.

4 August 2015 – Survey on World Malaria Report 2014

The WHO Global Malaria Programme is conducting an online survey on the latest World Malaria Report. The results will be used to improve the content and structure of future editions.

4 August 2015 – New publication: Elimination of malaria in Tunisia

The 10th and final report in the elimination case studies series, produced jointly by WHO and the Global Health Group, focuses on Tunisia's successful elimination of malaria. The report is also available in French.

29 July 2015 – Technical brief on control and elimination of P. vivax malaria

The technical brief covers several key strategic areas aimed at controlling and eliminating P. vivax including diagnostic testing and treatment, G6PD deficiency and radical cure with primaquine, and surveillance.

World Malaria Report 2014

This report contains the latest available data on malaria policies, interventions and trends in all endemic countries.

Global Technical Strategy for Malaria 2016-2030

Adopted by the World Health Assembly in May 2015, this strategy aims to reduce global malaria incidence and mortality rates by 90% by 2030.

Contact us

Global Malaria Programme
World Health Organization
20 Avenue Appia
1211 Geneva 27
Tel: +41 22 791 2533
Fax: +41 22 791 4824